These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1566422)

  • 1. Low rate of white graft reaction (skin hyperacute rejection) in skin xenografts with recipient preformed antibodies.
    Thomas FT
    Transplant Proc; 1992 Apr; 24(2):544-5. PubMed ID: 1566422
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of xenograft hyperacute rejection via xenoantibody depletion.
    Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM
    Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term survival of xenogeneic skin grafts in widely disparate combinations.
    Bouwman E; Wolvekamp MC; Scheringa M; de Bruin RW; Bonthuis F; Jeekel J; Marquet RL
    Transplant Proc; 1993 Feb; 25(1 Pt 1):383-4. PubMed ID: 8438345
    [No Abstract]   [Full Text] [Related]  

  • 4. Normal rejection of xenografts by strongly deficient B-cell animals (X-linked immunodeficient mice).
    Patselas T; Marchman W; Araneda D; Thomas J; Thomas F
    Transplant Proc; 1992 Apr; 24(2):494. PubMed ID: 1566401
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of primary xenograft or allograft on the rejection of a subsequent allograft.
    Tchervenkov CI; Shum-Tim D; Serrick CJ; Gyopar A; Lough JO; Tchervenkov JI
    Transplant Proc; 1993 Feb; 25(1 Pt 1):453-4. PubMed ID: 8438376
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended and expanded studies of xenograft rejection in immunodeficient animals.
    Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
    Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
    [No Abstract]   [Full Text] [Related]  

  • 7. Xenograft adaptation is dependent on the presence of antispecies antibody, not prolonged residence in the recipient.
    Hasan R; Van den Bogaerde J; Forty J; Wright L; Wallwork J; White DJ
    Transplant Proc; 1992 Apr; 24(2):531-2. PubMed ID: 1566418
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 9. Distribution of xenogeneic target antigens detected by a monoclonal antibody capable of inducing hyperacute rejection of hamster cardiac xenografts in rats.
    Wu GD; Cramer DV; Kearns M; Eiras-Hreha G; Makowka L
    Transplant Proc; 1994 Jun; 26(3):1382-3. PubMed ID: 8029949
    [No Abstract]   [Full Text] [Related]  

  • 10. Examination of the clonal deletion theory in the guinea pig to Lewis rat cardiac xenograft model.
    Boyle EM; Fischel RJ; Johnson EM; Leventhal J; Matas AJ; Bolman RM
    Transplant Proc; 1992 Apr; 24(2):632. PubMed ID: 1566458
    [No Abstract]   [Full Text] [Related]  

  • 11. Accommodated xenografts survive in the presence of anti-donor antibodies and complement that precipitate rejection of naive xenografts.
    Lin Y; Soares MP; Sato K; Takigami K; Csizmadia E; Smith N; Bach FH
    J Immunol; 1999 Sep; 163(5):2850-7. PubMed ID: 10453031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of mouse-to-rat skin xenograft rejection by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1996 Dec; 28(6):3037-9. PubMed ID: 8962179
    [No Abstract]   [Full Text] [Related]  

  • 13. Prolongation of xenograft survival by exchange transfusions and immunosuppression.
    Bouwman E; de Bruin RW; Jeekel J; Marquet RL
    Transplant Proc; 1990 Jun; 22(3):1079-80. PubMed ID: 2190374
    [No Abstract]   [Full Text] [Related]  

  • 14. Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
    Jeyarajah DR; Schmeisser FS; Josephson MA; Sohn DG; Thistlethwaite JR
    Transplant Proc; 1994 Apr; 26(2):771-3. PubMed ID: 8171656
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of hamster-to-rat cardiac xenograft survival by hyperimmune blood transfusion without immunosuppression.
    Lee PC; Lei HY; Hung CJ; Arakawa K; Oka T
    Transplant Proc; 1996 Jun; 28(3):1397-9. PubMed ID: 8658711
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression in xenotransplantation.
    Hammer C
    Transplant Proc; 1996 Dec; 28(6):3017-20. PubMed ID: 8962171
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of accommodation prevents hyperacute rejection.
    Vriens PW; Bouwman E; Scheringa M
    Transplant Proc; 1997; 29(1-2):597-8. PubMed ID: 9123147
    [No Abstract]   [Full Text] [Related]  

  • 18. Administration of tacrolimus (FK506) in hamster-to-rat pancreas xenotransplantation.
    Sakimoto H; Fukuda Y; Sumimoto K; Urushihara T; Ikeda M; Yamanaka K; Okugawa K; Nishihara M; Ito H; Dohi K
    Transplant Proc; 1996 Jun; 28(3):1433-4. PubMed ID: 8658727
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of protection from humoral rejection by a xenografted liver.
    Celli S; Valdivia LA; Kelly RH; Sun H; Tsugita M; Pan F; Rao AS; Demetris AJ; Fung JJ; Starzl TE
    Transplant Proc; 1995 Feb; 27(1):300-2. PubMed ID: 7533395
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac and skin xenograft survival in different recipient mouse strains.
    Gock H; Murray-Segal L; Salvaris E; Fisicaro N; Cowan PJ; d'Apice AJ
    Transplantation; 2006 Nov; 82(10):1362-9. PubMed ID: 17130786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.